ACON Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Chartmill - Mentions: IRBT GCO CCRN BBW ...

Gapping stocks in Thursday's session

13 days ago - By: Chartmill - Mentions: SLP AXTI PRPH MDB ...

Which stocks are gapping on Tuesday?

11 days ago - By: Aclarion, Inc.

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

25 days ago - By: Benzinga - Mentions: JACK NVDA ACM LLY ...

Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday

a month ago - By: Aclarion, Inc.

Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

2 months ago - By: Aclarion, Inc.

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

2 months ago - By: Benzinga - Mentions: SSII DBVT NDRA RCKT ...

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

2 months ago - By: Aclarion, Inc.

Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst

2 months ago - By: Aclarion, Inc.

Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference

2 months ago - By: Aclarion, Inc.

Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

3 months ago - By: Aclarion, Inc.

Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers

3 months ago - By: Aclarion, Inc.

First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial

3 months ago - By: Aclarion, Inc.

Aclarion Appoints Greg Gould as Chief Financial Officer

4 months ago - By: Zacks Investment Research - Mentions: AMN

AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates

4 months ago - By: Aclarion, Inc.

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

5 months ago - By: Aclarion, Inc.

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

6 months ago - By: Aclarion, Inc.

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

6 months ago - By: Aclarion, Inc.

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

6 months ago - By: Aclarion, Inc.

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

7 months ago - By: Aclarion, Inc.

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

7 months ago - By: Aclarion, Inc.

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

7 months ago - By: Aclarion, Inc.

Aclarion Welcomes Advocate Health as CLARITY Trial Site

8 months ago - By: Aclarion, Inc.

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

8 months ago - By: Aclarion, Inc.

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

8 months ago - By: Aclarion, Inc.

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

8 months ago - By: Aclarion, Inc.

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

9 months ago - By: Aclarion, Inc.

ACLARION INC (ACON) Stock News

ACON Latest News, Press Relases and Analysis

Gapping stocks in Thursday's session

Which stocks are gapping on Tuesday?

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday

Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

Aclarion Wins “Rising Star” at 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst

Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference

Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH

Aclarion Presents at LSI Europe ’25 Highlighting Nociscan Technology and Key Value Drivers

First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial

Aclarion Appoints Greg Gould as Chief Financial Officer

AMN Healthcare Services (AMN) Tops Q2 Earnings and Revenue Estimates

Aclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming Catalysts

Aclarion, Inc. Announces Adjournment of Annual Meeting of Stockholders

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

Aclarion to Present NOCISCAN Technology at Leading Spine Innovation Forum

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Welcomes Advocate Health as CLARITY Trial Site

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California